US Drugs For Malaria Market: Advancements in Antimalarial Treatment by 2034
The US Drugs For Malaria Market also benefits from advanced diagnostic and healthcare infrastructure. Rapid identification of malaria infections can support timely treatment and appropriate selection of antimalarial medicines. The Drugs for Malaria Market was valued at US$ 4.42 Billion in 2025 and is expected to reach US$ 7.26 Billion by 2034, registering a CAGR of 5.67% during 2026–2034....
0 Comments 0 Shares 10 Views 0 Reviews